The FDA has launched Elsa, a generative AI tool aimed at enhancing operational efficiency across the agency. Designed to assist employees with tasks such as reading, writing, and summarizing, Elsa will streamline processes like clinical protocol reviews and safety profile assessments while ensuring data security. This initiative marks the beginning of the FDA's broader integration of AI technologies.